Pricing Log in Create free account

Artelo Biosciences, Inc. (ARTL) vs Lakewood-Amedex Biotherapeutics Inc. (LABT)

Artelo Biosciences, Inc. and Lakewood-Amedex Biotherapeutics Inc. are both Biotechnology companies. Artelo Biosciences, Inc. and Lakewood-Amedex Biotherapeutics Inc. are of similar size ($1.3M and $1.2M). Across the 10 metrics below, Artelo Biosciences, Inc. leads on 5 and Lakewood-Amedex Biotherapeutics Inc. on 5.

Valuation

Metric ARTL LABT Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.12 0.12 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.33 0.71 0.66
EV/Sales n/m n/m 9.02
Earnings yield (10,336.94%) (2,135.14%) (32.88%)
Free cash flow yield (2,139.52%) (934.12%) (23.13%)

Profitability

Metric ARTL LABT Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (705.71%) 0.00% (51.96%)
Return on assets (234.30%) (302.50%) (46.06%)
Return on invested capital (865.85%) 0.00% 0.00%

Growth

Metric ARTL LABT Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 31.57% 15.32% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ARTL LABT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.00 7.70 4.97
Net debt to EBITDA 0.05 0.06 1.01

Dividend

Metric ARTL LABT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ARTL LABT Biotechnology median
Market cap 1.16m 1.27m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack